Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Visentin

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Cardiovascular Pharmacology|April 1, 1990
Cardiac electrophysiologic effects of a new calcium antagonist, lacidipineE Cerbai, P DeBonfioli Cavalcabó, I Masini, et al.
Pharmaceutical Research|June 19, 2001
Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activitiesC Cena, S Visentin, A Di Stilo, et al.
Acta Diabetologica|May 28, 2017
Team management of gestational diabetes: a training experienceS Burlina, M G Dalfrà, S Visentin, et al.
Physics in Medicine and Biology|October 9, 2014
Estimation of prenatal aorta intima-media thickness from ultrasound examinationE Veronese, G Tarroni, S Visentin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 24, 2018
Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposesG Ermondi, M Vallaro, M P Camacho-Leal, et al.
Journal of Medicinal Chemistry|January 6, 1999
New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activitiesA Di Stilo, S Visentin, C Cena, et al.
Experimental Neurology|July 27, 2015
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiationC De Nuccio, A Bernardo, C Cruciani, et al.
Pharmaceutical Research|July 9, 1999
NO donor and biological properties of different benzofuroxansC Medana, A Di Stilo, S Visentin, et al.
Archives of Internal Medicine|November 14, 2001
Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive casesM Fraquelli, A Losco, S Visentin, et al.
Minerva Anestesiologica|December 13, 2006
Hypertrophic obstructive cardiomyopathy and pregnancy: anesthesiological observations and clinical seriesM A Pitton, M Petolillo, E Munegato, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Cardiovascular Pharmacology|April 1, 1990
Cardiac electrophysiologic effects of a new calcium antagonist, lacidipineE Cerbai, P DeBonfioli Cavalcabó, I Masini, et al.
Pharmaceutical Research|June 19, 2001
Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activitiesC Cena, S Visentin, A Di Stilo, et al.
Acta Diabetologica|May 28, 2017
Team management of gestational diabetes: a training experienceS Burlina, M G Dalfrà, S Visentin, et al.
Physics in Medicine and Biology|October 9, 2014
Estimation of prenatal aorta intima-media thickness from ultrasound examinationE Veronese, G Tarroni, S Visentin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 24, 2018
Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposesG Ermondi, M Vallaro, M P Camacho-Leal, et al.
Journal of Medicinal Chemistry|January 6, 1999
New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activitiesA Di Stilo, S Visentin, C Cena, et al.
Experimental Neurology|July 27, 2015
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiationC De Nuccio, A Bernardo, C Cruciani, et al.
Pharmaceutical Research|July 9, 1999
NO donor and biological properties of different benzofuroxansC Medana, A Di Stilo, S Visentin, et al.
Archives of Internal Medicine|November 14, 2001
Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive casesM Fraquelli, A Losco, S Visentin, et al.
Minerva Anestesiologica|December 13, 2006
Hypertrophic obstructive cardiomyopathy and pregnancy: anesthesiological observations and clinical seriesM A Pitton, M Petolillo, E Munegato, et al.
Pageof 7